D-CAG (decitabine followed by cytarabine, aclarubicin, and G-CSF) for relapsed acute myeloid leukemia after hematopoietic cell transplantation

Runhui Zheng; Bailu Xie; Chunyan Wang; Baodan Yu; Jun Xu; Huo Tan

doi:10.1007/s00277-015-2505-x

D-CAG (decitabine followed by cytarabine, aclarubicin, and G-CSF) for relapsed acute myeloid leukemia after hematopoietic cell transplantation

Runhui Zheng, Bailu Xie, Chunyan Wang, Baodan Yu, Jun Xu, Huo Tan

Department of Life Sciences

Research output: Contribution to journal › Article › peer-review

6 Citations (SciVal)

Original language	English
Pages (from-to)	157-159
Journal	Annals of Hematology
Volume	95
Issue number	1
Early online date	18 Sept 2015
DOIs	https://doi.org/10.1007/s00277-015-2505-x
Publication status	Published - Jan 2016

Access to Document

10.1007/s00277-015-2505-x

Cite this

@article{abc9f193e3854ae1b4956d238f89a172,

title = "D-CAG (decitabine followed by cytarabine, aclarubicin, and G-CSF) for relapsed acute myeloid leukemia after hematopoietic cell transplantation",

author = "Runhui Zheng and Bailu Xie and Chunyan Wang and Baodan Yu and Jun Xu and Huo Tan",

year = "2016",

month = jan,

doi = "10.1007/s00277-015-2505-x",

language = "English",

volume = "95",

pages = "157--159",

journal = "Annals of Hematology",

issn = "0939-5555",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "1",

}

TY - JOUR

T1 - D-CAG (decitabine followed by cytarabine, aclarubicin, and G-CSF) for relapsed acute myeloid leukemia after hematopoietic cell transplantation

AU - Zheng, Runhui

AU - Xie, Bailu

AU - Wang, Chunyan

AU - Yu, Baodan

AU - Xu, Jun

AU - Tan, Huo

PY - 2016/1

Y1 - 2016/1

UR - http://www.scopus.com/inward/record.url?scp=84941729874&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1007/s00277-015-2505-x

U2 - 10.1007/s00277-015-2505-x

DO - 10.1007/s00277-015-2505-x

M3 - Article

SN - 0939-5555

VL - 95

SP - 157

EP - 159

JO - Annals of Hematology

JF - Annals of Hematology

IS - 1

ER -

D-CAG (decitabine followed by cytarabine, aclarubicin, and G-CSF) for relapsed acute myeloid leukemia after hematopoietic cell transplantation

Access to Document

Other files and links

Cite this